EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis

Leon Kircik, Abby Jacobson

Journal of Drugs in Dermatology · 01.02.2024 · 23 (2) · 50-53

DOI: 10.36849/jdd.7928 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.01.2024. Verfasst von Leon Kircik und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Psoriasis, Nicotinic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatologic AgentsPsoriasisNicotinic AcidsAdultHumansDrug CombinationsQuality of LifeTreatment OutcomeSeverity of Illness IndexSkin CreamClobetasolPruritusCeramidesDouble-Blind MethodRetinoids

Substanzen

Drug CombinationsDermatologic AgentsClobetasolNicotinic AcidsCeramideshalobetasoltazaroteneRetinoids

Zitieren

APA

Kircik, L., & Jacobson, A. (2024). Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis. Journal of Drugs in Dermatology, 23(2), 50-53. https://doi.org/10.36849/jdd.7928

Vancouver

Kircik L, Jacobson A. Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis. Journal of Drugs in Dermatology. 2024;23(2):50-53. doi:10.36849/jdd.7928

BibTeX
@article{Kircik2024,
  author = {Kircik, Leon and Jacobson, Abby},
  title = {Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  volume = {23},
  number = {2},
  pages = {50--53},
  doi = {10.36849/jdd.7928}
}
Kostenlos starten →